Delphi consensus recommendation for optimization of pulmonary hypertension therapy focusing on switching from a phosphodiesterase 5 inhibitor to riociguat.

Autor: Rahaghi FF; Advanced Lung Disease Clinic Cleveland Clinic Florida Weston Florida USA., Balasubramanian VP; UCSF Fresno Fresno California USA., Bourge RC; The University of Alabama at Birmingham Birmingham Alabama USA., Burger CD; Mayo Clinic Jacksonville Florida USA., Chakinala MM; Washington University St. Louis Missouri USA., Eggert MS; Sentara Heart Hospital Norfolk Virginia USA., Elwing JM; University of Cincinnati Cincinnati Ohio USA., Feldman J; Arizona Pulmonary Specialists Phoenix Arizona USA., King C; Inova Fairfax Hospital Falls Church Virginia USA., Klinger JR; Rhode Island Hospital Brown University Providence Rhode Island USA., Mathai SC; Johns Hopkins Hospital Baltimore Maryland USA., McConnell JW; University of Kentucky Louisville Kentucky USA., Palevsky HI; University of Pennsylvania Philadelphia Pennsylvania USA., Restrepo-Jaramillo R; University of South Florida Tampa Florida USA., Safdar Z; Center for Advanced Lung Diseases, Houston Methodist Hospital Weill Cornell Medicine Houston Texas USA., Sager JS; Cottage Pulmonary Hypertension Center Santa Barbara California USA., Sood N; University of California-Davis Sacramento California USA., Sulica R; NYU Langone Health New York New York USA., White RJ; University of Rochester Medical Center Rochester New York USA., Hill NS; Tufts Medical Center Boston Massachusetts USA.

Publikováno v: Pulmonary circulation [Pulm Circ] 2022 Apr 07; Vol. 12 (2), pp. e12055. Date of Electronic Publication: 2022 Apr 07 (Print Publication: 2022).

Participation in pulmonary hypertension support group improves patient-reported health quality outcomes: a patient and caregiver survey.

Autor: Giri PC; Pulmonary and Critical Care Department, Loma Linda University Medical Center, Loma Linda, CA, USA., Stevens GJ; Pulmonary and Critical Care Department, Loma Linda University Medical Center, Loma Linda, CA, USA., Merrill-Henry J; Respiratory Care Department, Loma Linda University Medical Center, Loma Linda, CA, USA., Oyoyo U; Department of Dental Education Services, Loma Linda University School of Dentistry, Loma Linda, CA, USA., Balasubramanian VP; Pulmonary and Critical Care Department, University of California San Francisco-Fresno, Fresno, CA, USA.

Publikováno v: Pulmonary circulation [Pulm Circ] 2021 May 17; Vol. 11 (2), pp. 20458940211013258. Date of Electronic Publication: 2021 May 17 (Print Publication: 2021).

Real-world experience with riociguat as potential bridging therapy in patients with chronic thromboembolic pulmonary hypertension: a case series.

Autor: Balasubramanian VP; Division of Pulmonary Disease and Critical Care Medicine, University of California, Fresno, CA, USA., Beutner M; Division of Pulmonary Disease and Critical Care Medicine, University of California, Fresno, CA, USA., Gill K; Division of Pulmonary Disease and Critical Care Medicine, University of California, Fresno, CA, USA., Kakol M; Division of Pulmonary Disease and Critical Care Medicine, University of California, Fresno, CA, USA.; University of New Mexico medical center at Albuquerque, NM, USA., Melendres-Groves L; Division of Pulmonary Disease and Critical Care Medicine, University of California, Fresno, CA, USA.; University of New Mexico medical center at Albuquerque, NM, USA.

Publikováno v: Pulmonary circulation [Pulm Circ] 2020 Apr 16; Vol. 10 (2), pp. 2045894019898377. Date of Electronic Publication: 2020 Apr 16 (Print Publication: 2020).

Recommendations for the clinical management of patients receiving macitentan for pulmonary arterial hypertension (PAH): A Delphi consensus document.

Autor: Rahaghi FF; 1 Cleveland Clinic Florida, Weston, FL, USA., Alnuaimat HM; 2 Shands Hospital, University of Florida, Gainesville, FL, USA., Awdish RLA; 3 Henry Ford Hospital, Detroit, MI, USA., Balasubramanian VP; 4 UCSF Fresno, Fresno CA, USA., Bourge RC; 5 The University of Alabama at Birmingham, Birmingham, AL, USA., Burger CD; 6 Mayo Clinic, Jacksonville, FL, USA., Butler J; 7 The Oregon Clinic, Portland, OR, USA., Cauthen CG; 8 Providence Hospitals, Columbia, SC, USA., Chakinala MM; 9 Washington University School of Medicine, St Louis, MO, USA., deBoisblanc BP; 10 Louisiana State University Health Sciences Center, New Orleans, LA, USA., Eggert MS; 11 Sentara Heart Hospital, Norfolk, VA, USA., Engel P; 12 Ohio Heart & Vascular Center; The Christ Hospital, Cincinnati OH, USA., Feldman J; 13 Arizona Pulmonary Specialists, Phoenix, AZ, USA., McConnell JW; 14 University of Kentucky, Louisville, KY, USA., Park M; 15 Houston Methodist Hospital, Houston, TX, USA., Sager JS; 16 Cottage Pulmonary Hypertension Center, Santa Barbara, CA, USA., Sood N; 17 Ohio State University, Columbus, OH, USA., Palevsky HI; 18 University of Pennsylvania, Philadelphia, PA, USA.

Publikováno v: Pulmonary circulation [Pulm Circ] 2017 Jul-Sep; Vol. 7 (3), pp. 702-711. Date of Electronic Publication: 2017 Aug 22.

Pneumocystis carinii pneumonia with pleural effusion in a non-HIV host.

Autor: Balasubramanian VP; Division of Pulmonary and Critical Care Medicine and Department of Pathology, Medical College of Wisconsin, Milwaukee 53226, USA., Komorowski RA, Santo Tomas LH

Publikováno v: WMJ : official publication of the State Medical Society of Wisconsin [WMJ] 2006 Jan; Vol. 105 (1), pp. 62-5.